Dr. Agarwal’s Health Care Limited will announce its audited financial results for the quarter and year ended March 31, 2026, on May 21, 2026. Following the board meeting, the company will host an analyst conference call to discuss its performance. Key leadership, including the CEO and CFO, will represent the company to provide insights into the annual financials and address investor queries.
Board Meeting Details
The Board of Directors of Dr. Agarwal’s Health Care Limited is scheduled to convene on Thursday, May 21, 2026. The primary objective of this meeting is to review and approve the company’s audited financial results, both on a standalone and consolidated basis, for the quarter and fiscal year ending March 31, 2026.
Investor and Analyst Conference Call
To facilitate transparency, the company will host an earnings conference call on May 21, 2026, between 06:30 P.M. and 07:30 P.M. (IST). This session is designed to allow investors and market analysts to engage with the leadership team regarding the annual financial performance.
Leadership Representation
The management team presenting on the call will include:
- Dr. Adil Agarwal – Whole-time Director and Chief Executive Officer
- Mr. Yashwanth Venkat – Chief Financial Officer
- Ms. Aashna Dharia – Head, Investor Relations
Participation Information
Participants are requested to dial in 10 minutes ahead of the scheduled start time. International investors can access the call via toll-free numbers provided for various regions, including USA, UK, Singapore, and Japan. Domestic participants can join using the designated Indian dial-in lines. An Express Diamond Pass link is also available for seamless registration and entry to the conference call.
Source: BSE
